Workplace interventions to reduce depression and anxiety in small and medium-sized enterprises: A systematic review.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 17 10 2020
revised: 14 01 2021
accepted: 25 04 2021
pubmed: 4 6 2021
medline: 6 7 2021
entrez: 3 6 2021
Statut: ppublish

Résumé

Depression and anxiety are the most prevalent mental health difficulties in the workplace, costing the global economy $1 trillion each year. Evidence indicates that symptoms may be reduced by interventions in the workplace. This paper is the first to systematically review psychosocial interventions for depression, anxiety, and suicidal ideation and behaviours in small-to medium-size enterprises (SMEs). A systematic search following PRISMA guidelines, registered in PROSPERO (CRD42020156275), was conducted for psychosocial interventions targeting depression, anxiety, and suicidal ideation/behaviour in SMEs. The PubMed, PsycINFO, Scopus, and two specific occupational health databases were searched, as well as four databases for grey literature, without time limit until 2nd December 2019. In total, 1283 records were identified, 70 were retained for full-text screening, and seven met the inclusion criteria: three randomised controlled trials (RCTs), three before and after designs and one non-randomised trial, comprising 5111 participants. Study quality was low to moderate according to the Quality Assessment Tool for Quantitative Studies. Five studies showed a reduction in depression and anxiety symptoms using techniques based on cognitive behavioural therapy (CBT), two reported no significant change. Low number and high heterogeneity of interventions and outcomes, high attrition and lack of rigorous RCTs. Preliminary evidence indicates CBT-based interventions can be effective in targeting symptoms of depression and anxiety in SME employees. There may be unique challenges to implementing programmes in SMEs. Further research is needed in this important area.

Sections du résumé

BACKGROUND
Depression and anxiety are the most prevalent mental health difficulties in the workplace, costing the global economy $1 trillion each year. Evidence indicates that symptoms may be reduced by interventions in the workplace. This paper is the first to systematically review psychosocial interventions for depression, anxiety, and suicidal ideation and behaviours in small-to medium-size enterprises (SMEs).
METHODS
A systematic search following PRISMA guidelines, registered in PROSPERO (CRD42020156275), was conducted for psychosocial interventions targeting depression, anxiety, and suicidal ideation/behaviour in SMEs. The PubMed, PsycINFO, Scopus, and two specific occupational health databases were searched, as well as four databases for grey literature, without time limit until 2nd December 2019.
RESULTS
In total, 1283 records were identified, 70 were retained for full-text screening, and seven met the inclusion criteria: three randomised controlled trials (RCTs), three before and after designs and one non-randomised trial, comprising 5111 participants. Study quality was low to moderate according to the Quality Assessment Tool for Quantitative Studies. Five studies showed a reduction in depression and anxiety symptoms using techniques based on cognitive behavioural therapy (CBT), two reported no significant change.
LIMITATIONS
Low number and high heterogeneity of interventions and outcomes, high attrition and lack of rigorous RCTs.
CONCLUSIONS
Preliminary evidence indicates CBT-based interventions can be effective in targeting symptoms of depression and anxiety in SME employees. There may be unique challenges to implementing programmes in SMEs. Further research is needed in this important area.

Identifiants

pubmed: 34082284
pii: S0165-0327(21)00403-1
doi: 10.1016/j.jad.2021.04.071
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-386

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Bridget Hogg (B)

Centre Fòrum Research Unit, Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; PhD Programme, Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain.

Joan Carles Medina (JC)

Faculty of Psychology and Education Sciences, Universitat Oberta de Catalunya, Barcelona, Spain; Department of Clinical Psychology and Psychobiology, Universitat de Barcelona, Barcelona, Spain.

Itxaso Gardoki-Souto (I)

Centre Fòrum Research Unit, Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; PhD Programme, Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain.

Ilinca Serbanescu (I)

European Alliance Against Depression e.V., Leipzig, Germany; Department of Clinical Psychology and Psychotherapy, University of Heidelberg, Heidelberg, Germany.

Ana Moreno-Alcázar (A)

Centre Fòrum Research Unit, Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBERSAM, Madrid, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain.

Arlinda Cerga-Pashoja (A)

Population Health, London School of Hygiene and Tropical Medicine, London, England; Global Public Health, Public Health England, United Kingdom.

Evelien Coppens (E)

LUCAS, Centre for Care Research and Consultancy, University of Leuven, Belgium.

Mónika Ditta Tóth (MD)

Institute of Behavioral Sciences, Semmelweis University, Budapest, Hungary.

Naim Fanaj (N)

Mental Health Center Prizren, Kosovo.

Birgit A Greiner (BA)

School of Public Health, College of Medicine and Health, National Suicide Research Foundation, University College Cork, Ireland.

Carolyn Holland (C)

National Suicide Research Foundation, Cork, Ireland; Health Service Executive, Cork, Ireland.

Kairi Kõlves (K)

Australian Institute for Suicide Research and Prevention, Griffith University.

Margaret Maxwell (M)

Nursing, Midwifery and Allied Health Professions Research Unit, University of Stirling, Scotland, United Kingdom.

Gentiana Qirjako (G)

Department of Public Health, Faculty of Medicine, University of Medicine, Tirana, Albania.

Lars de Winter (L)

Phrenos Center of Expertise for severe mental illness, Utrecht, the Netherlands.

Ulrich Hegerl (U)

European Alliance Against Depression e.V., Leipzig, Germany; Research Centre of the German Depression Foundation, Leipzig, Germany; Department of Psychiatry, Psychosomatics and Psychotherapy, Goethe-Universität Frankfurt, Frankfurt, Germany.

Victor Pérez-Sola (V)

IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBERSAM, Madrid, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain; Institut de Neuropsiquiatria i Addiccions (INAD), Hospital del Mar, Barcelona, Spain.

Ella Arensman (E)

School of Public Health, College of Medicine and Health, National Suicide Research Foundation, University College Cork, Ireland; National Suicide Research Foundation, Cork, Ireland; Australian Institute for Suicide Research and Prevention, Griffith University; International Association for Suicide Prevention (IASP), Washington DC, USA. Electronic address: ella.arensman@ucc.ie.

Benedikt L Amann (BL)

Centre Fòrum Research Unit, Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBERSAM, Madrid, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain; Institut de Neuropsiquiatria i Addiccions (INAD), Hospital del Mar, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH